This federal contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization focused on developing HIV vaccines. The $5,040,022 award supports IAVI's work on "Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents" under a larger IDIQ contract vehicle with NIAID for these services. The contract does not have a set-aside designation. IAVI serves as the prime contractor and leverages its expertise in immunology, manufacturing, regulatory affairs, and clinical trial planning to advance promising vaccine candidates through preclinical and clinical testing. This work is part of IAVI's broader mission to develop safe, effective, and accessible preventive HIV vaccines worldwide.
Generated 5/14/24, 12:03 PM